J. S. Landells et al. / Tetrahedron Letters 44 (2003) 5193–5196
5195
Figure 2. The molecular structure of 10.
fact that the specific rotation for the natural product
had a reported value of [h]D +42 (c 0.9, CHCl3).8,9 The
sign and the magnitude of this rotation, in comparison
to that measured by us, brings into doubt either the
original assignment of the structure of natural 6 or the
reporting of these data.
with the high facial selectivity of complex 9, results in
an effective kinetic resolution of the diene component.
We have demonstrated the utility of this approach with
the first asymmetric syntheses of (−)-tetrangomycin 6 in
31% overall yield with ee ranging from 68 to 78% and
(−)-MM 47755 13 in 28% overall yield with a 70% ee.
Recrystallisation of the reaction intermediates resulted
in an increase in their ee’s and gave (−)-6 with 98% ee.
An X-ray crystallographic study of 10 unambiguously
established the absolute configurations of (−)-6 and
(−)-13 as 3R. This synthesis required a stoichiometric
amount of the chiral Lewis acid to promote the pivotal
asymmetric Diels–Alder reaction. Further work investi-
gating the use of chiral Lewis acid catalysts to effect
kinetic resolutions of racemic dienes using Diels–Alder
reactions of the type described is warranted.
The related angucyclinone MM 47755 13, which is the
8-O-methyl congener of 6, has been independently iso-
lated by two groups.10,11 They reported the specific
rotations for 13 as [h]D −107 (c 0.5, MeOH) and −136
(c 0.04, MeOH), respectively. Treatment of the angucy-
clinone 12 (ee 70%) with methyl iodide and silver(I)
oxide gave, after photochemical oxidation of methyl
ether 14 in methanol, (−)-13 in a 70% yield for the two
steps. The specific rotation was measured as [h]D −69 (c
0.7, MeOH) and the ee was assessed as 70% by NMR
methods.
References
The stereochemical outcome of the cycloaddition was
based on the model for asymmetric induction for the
Diels–Alder reactions of 9 proposed by Kelly et al.3 in
conjunction with that for the facial selectivity of diene
7 determined from NMR data of adduct 8a. This in
turn led to the assignment of the absolute configura-
tions of (−)-6 and (−)-13 both as 3R. Unambiguous
confirmation for these assignments came from minor
modifications to the reaction sequence. Recrystallisa-
tion of 10 from hot hexanes increased the ee to 90%. A
further crystallisation of a small amount of this mate-
rial gave crystals suitable for an X-ray crystallographic
study12 the solution of which is shown in Figure 2. On
the basis of the crystallographic data the configuration
of 10 was determined as 3S and thus, those of (−)-6 and
(−)-13 as 3R. Continuation of the synthesis outlined in
Scheme 1 using 10 (90% ee), with recrystallisation of
each intermediate, gave (−)-tetrangomycin 6 with an
optical rotation [h]D −100 (c 0.26, MeOH) and with an
ee of 98%.
1. Whiting, A. Adv. Asymm. Synth. 1996, 126–145.
2. Larsen, D. S.; O’Shea, M. D.; Brooker, S. Chem. Com-
mun. 1996, 203–204.
3. Kelly, T. R.; Whiting, A.; Chandrakumar, N. S. J. Am.
Chem. Soc. 1986, 108, 3510–3512.
4. Carren˜o, M. C.; Urbano, A.; Di Vitta, C. Chem. Com-
mun. 1999, 817–818.
5. Carren˜o, M. C.; Urbano, A.; Di Vitta, C. Chem. Eur. J.
2000, 6, 906–913.
6. Krohn, K.; Khanbabaee, K. Leibigs Ann. Chem. 1994,
1109–1112.
7. Krohn, K.; Khanbabaee, K.; Micheel, J. Leibigs Ann.
Chem. 1995, 1529–1537.
8. Kuntsmann, M. P.; Mitscher, L. A. J. Org. Chem. 1966,
31, 2920–2925.
9. Dann, M. L. D.; Barbatschi, F.; Shu, P.; Kuntsmann, M.;
Mitscher, L.; Bohonos, N. Antimicrob. Agents
Chemother. 1965, 832–835.
10. Shigihara, Y.; Koizumi, Y.; Tamamura, T.; Homma, Y.;
Isshiki, K.; Dobashi, K.; Naganawa, H.; Takeuchi, T. J.
Antibiot. 1988, 41, 1260–1264.
In summary, we have shown that enantiomerically
enriched cycloadducts can be obtained from a chiral
Lewis acid Diels–Alder reaction of 1 and diene ( )-7.
The facial selectivity of ( )-7 is controlled by the
remote C-5 stereogenic centre which, in conjunction
11. Gilpin, M. L.; Balchin, J.; Box, S. J.; Tyler, J. W. J.
Antibiot. 1989, 42, 627–628.
12. Crystal data and structure refinement for 10: C27H26O3Si,
M=426.57, monoclinic, space group P2(1), a=